A randomized controlled trial on the impacts of attending-led ward rounds fully conducted at the bedside

A randomized controlled trial on how attending-led ward rounds fully conducted at the bedside - as compared with attending-led, traditional ward rounds - impact on patients' satisfaction, shared decision-making and disease knowledge

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN20414435

Enrollment

160

Registered

2013-04-15

Start date

2013-04-15

Completion date

Unknown

Last updated

2019-02-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patient outcomes in relation to specific care processes (ward rounds) Not Applicable

Interventions

Intervention round type (round fully conducted at the bedside) is compared with a controlled round type (round conducted on a traditional basis). The intervention pertains to the way

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Patient to be seen during the attending-led ward round 2. Patients both men and women, above 16 years old, no upper age limit 3. Informed and signed consent form

Exclusion criteria

Exclusion criteria: 1. Cognitive impairment (documented dementia or positive dementia screening test) 2. Delirium (documented or positive screening test) 3. Altered consciousness 4. Terminally-ill state 5. Significant communication issue (language barrier; dysarthria; dysphasia; hearing impairment)

Design outcomes

Primary

Measure	Time frame
Patient understanding and knowledge of one?s own disease, which includes: 1. Patient self-perception of disease understanding (post-round questionnaire, with a 4-point ordinal scale: Yes = the ward round helps me understand my disease; Rather Yes; Rather No and No) 2. Knowledge gain about the disease, which means the gain allowed by the round (assessment of knowledge before and after the round, through audio-recording of disease narratives). 3. All the diseases? narratives undergo a numeric transformation, which gives an overall score between 3 and 9. A score of 3 means minimal understanding of the diagnosis (one point), of the treatment (one point) and of the prognosis (one point). A score of 9 means full understanding of the diagnosis (three points), of the treatment (three points) and of the prognosis (three points). Data will be gathered from the patients during two eight-week study periods. These periods can be considered as being the time intervals for outcomes measures, although full data analysis will last longer. Therefore, outcomes measures will last for two eight-week periods, starting as soon as possible in April (at the latest April 15) to the end of May/early June. The second outcome measures' period will last from Sept 2 to October 25.	—

Measure

Time frame

Patient understanding and knowledge of one?s own disease, which includes: 1. Patient self-perception of disease understanding (post-round questionnaire, with a 4-point ordinal scale: Yes = the ward round helps me understand my disease; Rather Yes; Rather No and No) 2. Knowledge gain about the disease, which means the gain allowed by the round (assessment of knowledge before and after the round, through audio-recording of disease narratives). 3. All the diseases? narratives undergo a numeric transformation, which gives an overall score between 3 and 9. A score of 3 means minimal understanding of the diagnosis (one point), of the treatment (one point) and of the prognosis (one point). A score of 9 means full understanding of the diagnosis (three points), of the treatment (three points) and of the prognosis (three points). Data will be gathered from the patients during two eight-week study periods. These periods can be considered as being the time intervals for outcomes measures, although full data analysis will last longer. Therefore, outcomes measures will last for two eight-week periods, starting as soon as possible in April (at the latest April 15) to the end of May/early June. The second outcome measures' period will last from Sept 2 to October 25.

—

Secondary

Measure	Time frame
1. Patient satisfaction (post-round questionnaire: with satisfaction assessed on an ordinal scale from 0= not satisfied at all to 10 = fully satisfied) 2. Patient involvement in the care process (post-round questionnaire, with a 4-point ordinal scale: Yes = I felt involved in the decision made during the ward rounds; Rather Yes; Rather No and No) 3. Patient anxiety (post-round questionnaire, with a 4-point ordinal scale: Yes = the ward round made me feel anxious; Rather Yes; Rather No and No) 4. Patient concerns about privacy issues (post-round questionnaire, with a 4-point ordinal scale: Yes = the medical team should be more concerned with privacy issues during ward round; Rather Yes; Rather No and No) 5. Patient overall experience of ward rounds, an assessment through three open-ended questions. Answers will be audio-recorded and semantically analyzed. Questions include: How did you experience today?s ward rounds? What went well? And What went not so well?	—

Measure

Time frame

1. Patient satisfaction (post-round questionnaire: with satisfaction assessed on an ordinal scale from 0= not satisfied at all to 10 = fully satisfied) 2. Patient involvement in the care process (post-round questionnaire, with a 4-point ordinal scale: Yes = I felt involved in the decision made during the ward rounds; Rather Yes; Rather No and No) 3. Patient anxiety (post-round questionnaire, with a 4-point ordinal scale: Yes = the ward round made me feel anxious; Rather Yes; Rather No and No) 4. Patient concerns about privacy issues (post-round questionnaire, with a 4-point ordinal scale: Yes = the medical team should be more concerned with privacy issues during ward round; Rather Yes; Rather No and No) 5. Patient overall experience of ward rounds, an assessment through three open-ended questions. Answers will be audio-recorded and semantically analyzed. Questions include: How did you experience today?s ward rounds? What went well? And What went not so well?

—

Countries

Switzerland

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026